tobramycin has been researched along with Fibrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Altenburg, J; Berk, Y; Boersma, WG; Bronsveld, I; de Kruif, MD; Heijerman, HGM; Rozemeijer, W; Snijders, D; Terpstra, LC | 1 |
| Cetinkaya, E; Chousein, EGU; Çınarka, H; Gul, S; Özgül, MA; Tanriverdi, E; Turan, D; Yildirim, BZ | 1 |
| Bregman, CL; Williams, PD | 1 |
3 other study(ies) available for tobramycin and Fibrosis
| Article | Year |
|---|---|
Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis.
Topics: Adolescent; Bronchiectasis; Cystic Fibrosis; Fibrosis; Humans; Quality of Life; Tobramycin | 2022 |
Results of Tobramycin Inhalation Therapy in Patients with Noncystic Fibrosis Bronchiectasis with
Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchiectasis; Cross-Sectional Studies; Fibrosis; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Therapy; Retrospective Studies; Tobramycin | 2021 |
Comparative nephrotoxicity of carboplatin and cisplatin in combination with tobramycin.
Topics: Animals; Antineoplastic Agents; Body Weight; Carboplatin; Cisplatin; Drug Synergism; Drug Therapy, Combination; Fibrosis; Kidney; Male; Organoplatinum Compounds; Rats; Rats, Inbred Strains; Tobramycin | 1986 |